212 related articles for article (PubMed ID: 25754447)
1. Absence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonism.
Khan MM; Zaheer S; Thangavel R; Patel M; Kempuraj D; Zaheer A
Neurochem Res; 2015 May; 40(5):980-90. PubMed ID: 25754447
[TBL] [Abstract][Full Text] [Related]
2. A role for glia maturation factor dependent activation of mast cells and microglia in MPTP induced dopamine loss and behavioural deficits in mice.
Selvakumar GP; Ahmed ME; Thangavel R; Kempuraj D; Dubova I; Raikwar SP; Zaheer S; Iyer SS; Zaheer A
Brain Behav Immun; 2020 Jul; 87():429-443. PubMed ID: 31982500
[TBL] [Abstract][Full Text] [Related]
3. Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation.
Kempuraj D; Selvakumar GP; Thangavel R; Ahmed ME; Zaheer S; Kumar KK; Yelam A; Kaur H; Dubova I; Raikwar SP; Iyer SS; Zaheer A
J Alzheimers Dis; 2018; 66(3):1117-1129. PubMed ID: 30372685
[TBL] [Abstract][Full Text] [Related]
4. Suppression of glia maturation factor expression prevents 1-methyl-4-phenylpyridinium (MPP⁺)-induced loss of mesencephalic dopaminergic neurons.
Khan MM; Zaheer S; Nehman J; Zaheer A
Neuroscience; 2014 Sep; 277():196-205. PubMed ID: 25016212
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
Javed H; Thangavel R; Selvakumar GP; Dubova I; Schwartz N; Ahmed ME; Zaheer S; Kempuraj D; Iyer S; Zaheer A; Khan MM
Int Immunopharmacol; 2020 Jun; 83():106441. PubMed ID: 32259702
[TBL] [Abstract][Full Text] [Related]
6. RESP18 deficiency has protective effects in dopaminergic neurons in an MPTP mouse model of Parkinson's disease.
Su J; Wang H; Yang Y; Wang J; Li H; Huang D; Huang L; Bai X; Yu M; Fei J; Huang F
Neurochem Int; 2018 Sep; 118():195-204. PubMed ID: 29964075
[TBL] [Abstract][Full Text] [Related]
7. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
Choi DY; Lee MK; Hong JT
Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
[TBL] [Abstract][Full Text] [Related]
8. Glia Maturation Factor (GMF) Regulates Microglial Expression Phenotypes and the Associated Neurological Deficits in a Mouse Model of Traumatic Brain Injury.
Ahmed ME; Selvakumar GP; Kempuraj D; Raikwar SP; Thangavel R; Bazley K; Wu K; Khan O; Khan A; Zaheer S; Iyer S; Burton C; James D; Zaheer A
Mol Neurobiol; 2020 Nov; 57(11):4438-4450. PubMed ID: 32737763
[TBL] [Abstract][Full Text] [Related]
9. Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons.
Hong J; Sha S; Zhou L; Wang C; Yin J; Chen L
Cell Death Dis; 2015 Jul; 6(7):e1832. PubMed ID: 26203861
[TBL] [Abstract][Full Text] [Related]
10. Molecular Association of Glia Maturation Factor with the Autophagic Machinery in Rat Dopaminergic Neurons: a Role for Endoplasmic Reticulum Stress and MAPK Activation.
Selvakumar GP; Iyer SS; Kempuraj D; Ahmed ME; Thangavel R; Dubova I; Raikwar SP; Zaheer S; Zaheer A
Mol Neurobiol; 2019 Jun; 56(6):3865-3881. PubMed ID: 30218400
[TBL] [Abstract][Full Text] [Related]
11. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
[TBL] [Abstract][Full Text] [Related]
13. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
14. Mice lacking Faim2 show increased cell death in the MPTP mouse model of Parkinson disease.
Komnig D; Schulz JB; Reich A; Falkenburger BH
J Neurochem; 2016 Dec; 139(5):848-857. PubMed ID: 27638043
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory mediators resulting from transglutaminase 2 expressed in mast cells contribute to the development of Parkinson's disease in a mouse model.
Hong GU; Cho JW; Kim SY; Shin JH; Ro JY
Toxicol Appl Pharmacol; 2018 Nov; 358():10-22. PubMed ID: 30195017
[TBL] [Abstract][Full Text] [Related]
16. The Nurr1 Ligand,1,1-bis(3'-Indolyl)-1-(
Hammond SL; Popichak KA; Li X; Hunt LG; Richman EH; Damale PU; Chong EKP; Backos DS; Safe S; Tjalkens RB
J Pharmacol Exp Ther; 2018 Jun; 365(3):636-651. PubMed ID: 29626009
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators.
Kempuraj D; Thangavel R; Yang E; Pattani S; Zaheer S; Santillan DA; Santillan MK; Zaheer A
PLoS One; 2015; 10(8):e0135776. PubMed ID: 26275153
[TBL] [Abstract][Full Text] [Related]
18. Glia maturation factor modulates beta-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage.
Zaheer A; Zaheer S; Thangavel R; Wu Y; Sahu SK; Yang B
Brain Res; 2008 May; 1208():192-203. PubMed ID: 18395194
[TBL] [Abstract][Full Text] [Related]
19. Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.
Annese V; Herrero MT; Di Pentima M; Gomez A; Lombardi L; Ros CM; De Pablos V; Fernandez-Villalba E; De Stefano ME
Brain Struct Funct; 2015 Mar; 220(2):703-27. PubMed ID: 24558048
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.
Al-Sweidi S; Morissette M; Bourque M; Di Paolo T
Neuropharmacology; 2011 Sep; 61(4):583-91. PubMed ID: 21586296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
